Our Story

AdvancedCPR SolutionsTM (ACS), develops and markets solutions to potentially improve survival outcomes from sudden cardiac arrest — the leading cause of death in the US and Europe of adults over 40 years of age, and the third largest cause of death overall (estimated at >470,000/yr. in the US).


Focused on solutions to
potentially improve survival
outcomes from sudden
cardiac arrest, estimated at
470,000
deaths per year in the US.


icon

The Problem:

Sudden Cardiac Arrest (SCA)

Sudden cardiac arrest, the abrupt loss of heart function that occurs when the heart’s electrical system malfunctions, is a leading cause of death globally, claiming a life every 90 seconds and taking more lives annually than breast cancer, lung cancer and HIV/AIDs combined. 1

In US, 470,000+ cardiac arrests annually
Dismal survival rates of 10.8% when SCA occurs out-of-hospital / 24% in-hospital
Few standard of care updates to improve SCA outcomes over last 50 years

Benjamin et al. (2018). Heart Disease and Stroke Statistics — 2018 Update. Circulation, 137, e355-e372. doi:10.1161/CIR.0000000000000558

The Solution:

ElevatedCPRTM Therapy
as Part of a Bundle of Care

ElevatedCPR therapy is a technologically-advanced method of performing device-assisted head up CPR that incorporates lifting the head, heart, and thorax in a multi-angled incline, in a timed sequence, in conjunction with best practice resuscitation protocols. ElevatedCPR therapy is intended to be used with a bundle of care, including active compression-decompression and/or mechanical CPR devices and an impedance threshold device (ITD), to help regulate the intrathoracic pressure while CPR is being performed.

When combined with the advanced post resuscitation therapies available today, the potential exists to increase survival from ~10% today to 40%+ over next 7-10 years
This translates to an additional 240,000+ lives saved annually and $672 billion estimated economic benefit to society yearly

Founded in Minneapolis, MN as Minnesota Resuscitation Solutions in 2015, AdvancedCPR Solutions is the pioneer of ElevatedCPR therapy, a broad, patent-protected evidence-based resuscitation therapy centered on patient positioning that could potentially improve survival from sudden cardiac arrest. Our early stage medical device firm is focused on the development and commercialization of ElevatedCPR therapy delivery mechanisms, methods, and devices.

The Science Behind ElevatedCPRTM Therapy

ElevatedCPR therapy, or device-assisted head up CPR, is a method for performing cardiopulmonary resuscitation (CPR) that incorporates lifting the head, heart, and thorax in a multi-angled incline, in a timed sequence. This positioning allows the body to drain venous blood from the brain while CPR is being performed; and pre-clinical evidence shows a number of benefits associated with this positioning relative to intracranial pressure (ICP), cerebral perfusion pressure (CerPP) and coronary perfusion pressure (CorPP).

ElevatedCPR therapy is intended to be used with a bundle of care including the EleGARDTM Patient Positioning System, active compression-decompression and/or mechanical CPR devices and an impedance threshold device (ITD) to help regulate the intrathoracic pressure while CPR is being performed.

Latest News

AdvancedCPR Solutions is Proud to be a Sponsor of the EMS STRONG Campaign.

May 20, 2019

AdvancedCPR Solutions is a proud sponsor of the 2019 EMS STRONG Campaign – BEYOND THE CALL. Produced in partnership with the American College of Emergency Physicians (ACEP) and the National Association of Emergency Medical Technicians (NAEMT), the

Read More |

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc nec porta tortor, ac suscipit arcu. Suspendisse mattis urna sit amet aliquet efficitur. Ut nec fringilla arcu, eu vulputate elit. In convallis turpis velit, quis rutrum turpis tristique rutrum.